These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 21228029

  • 81. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N, Pong A, Newman K, MD-10 Study Group.
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [Abstract] [Full Text] [Related]

  • 82. Development of oral cladribine for the treatment of multiple sclerosis.
    Hartung HP, Aktas O, Kieseier B, Giancarlo Comi GC.
    J Neurol; 2010 Feb; 257(2):163-70. PubMed ID: 19921304
    [Abstract] [Full Text] [Related]

  • 83. COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
    Dersch R, Wehrum T, Fähndrich S, Engelhardt M, Rauer S, Berger B.
    Mult Scler; 2020 Sep; 26(10):1264-1266. PubMed ID: 32762488
    [Abstract] [Full Text] [Related]

  • 84.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 85.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.
    Tzimos A, Samokhvalov V, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M.
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):31-43. PubMed ID: 18165460
    [Abstract] [Full Text] [Related]

  • 91. [Cladribine tablets : Oral immunotherapy of relapsing-remitting multiple sclerosis with short yearly treatment periods].
    Meuth SG, Ruck T, Aktas O, Hartung HP.
    Nervenarzt; 2018 Aug; 89(8):895-907. PubMed ID: 29523912
    [Abstract] [Full Text] [Related]

  • 92. Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
    Poveda JL, Trillo JL, Rubio-Terrés C, Rubio-Rodríguez D, Polanco A, Torres C.
    Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):295-303. PubMed ID: 31220959
    [Abstract] [Full Text] [Related]

  • 93. Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion.
    Meuth SG, Bayas A, Kallmann B, Kleinschnitz C, Linker R, Rieckmann P, Mäurer M.
    Expert Opin Pharmacother; 2020 Nov; 21(16):1965-1969. PubMed ID: 32658554
    [Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.